Gavin T. Cua

FDA investigator

Appears on 9 documents from 2022 to 2025, most often at sites in California. Most often cites general requirements (21 CFR 211.160).

9
Documents on file
3.1
Observations per 483
2022
First seen
2025
Most recent

What they cite most

From 28 observations

Activity by year

2022: 2, 2023: 4, 2024: 2, 2025: 1

Where

California 4 · India 2 · Canada 1 · Israel 1 · South Korea 1

Is Gavin T. Cua coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

9 documents, newest first
FirmOpen
483 Person and CoveyFeb 6, 2025 · Glendale, California
483 Natuzen Co.,Ltd.Nov 21, 2024 · Incheon, South Korea
483 ABRYL LABORATORIES PRIVATE LIMITEDAug 20, 2024 · SAS NAGAR, India
483 Natures Formulae Health Products Ltd.Nov 3, 2023 · Kelowna, Canada
483 Apex Healthcare LimitedJun 15, 2023 · Ankleshwar, India
483 Transfer Technology, Inc.Apr 28, 2023 · Huntington Beach, California
483 H J Harkins Company Inc dba Pharma PacMar 3, 2023 · Grover Beach, California

About this profile

What does Gavin T. Cua inspect?

Gavin T. Cua appears on 9 documents on file covering 9 sites, most often in California.

What do they cite most often?

21 CFR 211.160 (general requirements), followed by 21 CFR 211.22(a) and 21 CFR 211.100.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Gavin T. Cua is dated Feb 6, 2025.